recent articles

FRANKFURT, May 10 (Reuters) - Scientific journal Nature on Wednesday said a personalised treatment based on messenger RNA by BioNTech (22UAy.DE) potentially bodes well for the future of fighting an extremely aggressive form of cancer after the...

Collaborative research by Deep Bio and Dr. Lotan research team at Johns Hopkins Medicine was revealed at AUA 2023 SEOUL, SOUTH KOREA (PRWEB) MAY 11, 2023 - Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics support...

Evident Corporation (“Evident”) today announced the appointment of Eric Anderson, a current member of the Office of the CEO, as Interim CEO. He takes on the responsibilities of Yoshitake Saito, who assumes the role of Chairman effective...

Lunit and collaborators demonstrate the predictive value and analytical prowess of Lunit's AI-biomarker platform in a wide range of cancer types and clinical practices SEOUL, South Korea, May 10, 2023 /PRNewswire/ -- Lunit...

NIJMEGEN, Netherlands--(BUSINESS WIRE)--Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded a EUR 1.300.000 EFRO-OOST grant alongside Radboud university medical center and Pathologie-DNA to...

Pathomation is looking for an integration manager to support our expansion in the area of medical diagnostics software. At Pathomation the system integration manager plays an essential role to integrate Pathomation software in...

OR

platinum partners

gold partners

Silver Partners

Media Partners